Post Resch Tallon Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$440K Sell
3,422
-85
-2% -$9.95K 0.3% 60
2026
Q1
$427K Buy
3,507
+108
+3% +$12.5K 0.35% 55
2025
Q4
$358K Sell
3,399
-13
-0.4% -$1.22K 0.3% 59
2025
Q3
$286K Sell
3,412
-17
-0.5% -$1.4K 0.25% 73
2025
Q2
$271K Sell
3,429
-170
-5% -$13.5K 0.26% 68
2025
Q1
$313K Sell
3,599
-80
-2% -$7.47K 0.32% 60
2024
Q4
$365K Buy
+3,679
New +$379K 0.35% 51

Other funds holding MRK

Post Resch Tallon Group's MRK Position: Q2 2026 in Review

Post Resch Tallon Group reduced its Merck (MRK) stake by 2.4% in Q2 2026, selling an estimated $9.95K and leaving 3,422 shares worth $440K. The position accounts for 0.3% of the portfolio, ranked #60.

Post Resch Tallon Group first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Post Resch Tallon Group held 3,422 shares of Merck worth $440K as of Q2 2026.
  • Post Resch Tallon Group sold 85 Merck shares in Q2 2026, an estimated $9.95K.
  • Merck made up 0.3% of Post Resch Tallon Group's portfolio in Q2 2026, its #60 holding.
  • Post Resch Tallon Group first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Post Resch Tallon Group's 13F filing for Q2 2026, filed 7 Jul 2026.